(Q45392716)

14 December 2017

title

Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma (English)

1 reference

14 December 2017

1 reference

Takahiro Uenishi

1

1 reference

14 December 2017

Shuhei Nishiguchi

2

1 reference

14 December 2017

Shogo Tanaka

3

1 reference

14 December 2017

Takatsugu Yamamoto

4

1 reference

14 December 2017

Shigekazu Takemura

5

1 reference

14 December 2017

Shoji Kubo

6

1 reference

14 December 2017

publication date

1 October 2008

1 reference

Journal of Surgical Oncology

14 December 2017

published in

1 reference

14 December 2017

volume

98

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

358-362

1 reference

Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

14 December 2017

cites work

1 reference

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

21 January 2018

1 reference

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma

21 January 2018

1 reference

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.21111

1 reference

14 December 2017

1 reference